About us
Keuro MedTech
Keuro Medtech is focused on development, production, marketing and sales of vascular intervention medical devices.
Founded in 2019，Keuro MedTech has rapidly grown its team and achieved a business scope to be one of the leading vascular companies in China. In the next decade, Keuro MedTech is aiming to deliver innovation technology to improve the quality of life for patients worldwide.
Our Mission
Transforming care through technology — for every patient, every time
Our Facilities
| Facility | Function | Area |
| Shanghai | R&D Manufacture (Stents & Guidewires) Commercialization | 2500 m2 |
| Hangzhou | R&D Manufacture (Catheters & Balloons) | 2000 m2 |
| Jiangyin | Manufacture | 7,000m2 |
Keuro Medtech has an R&D office in Irvine, California, U.S. as well as commercial offices in Berlin, Germany and Minneapolis, Minnesota, U.S.
Our History
2019
- Company founded;
- Receiving Pre-A round funds of $2.7 MM
2020
- Receiving A-round funds of $13.7 MM
2021
- First product Locaste 8F Guiding Catheter approval in China;
- Receiving B-round funds of $13.7MM
2022
- Receiving B+-round funds of $31.6MM
2023
- Tarvos microguideiwre & JUEWA RX Balloon Catheter approved in China
2024
- Receiving C-round founds of $20.6 MM
- 200+ employees
- Revenue of $13.7 MM
2025
- Manufacturing site in Jiangyin of 7000 m2 is open for operation
2026
Quality Control
Keuro Medtech has solid expertise in the medical device complex regulatory environment. We design and manufacture medical devices in full compliance with US FDA, European MDR and China NMPA guidelines. Our manufacturing facilities are ISO 13485 certified.
